Verve Therapeutics, Inc.

Q4 2021 13F Holders

Symbol: VERV
CUSIP: 92539P101
Type: Equity
Class: COM
Num filings: 102
Total reported value, excl. options: $1.66 B

Compare 2021 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type